Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Cardiac amyloidosis in the spotlight at Heart Failure 2026
Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis .
AI uses 12-lead ECGs to predict long-term stroke risk
Stroke is still a leading cause of death all over the world. A new AI model showed early potential to anticipate such adverse outcomes up to a decade in advance, ensuring high-risk patients receive the care they need.
J&J launches Shockwave Medical’s next-generation coronary IVL catheter
The Shockwave C2 Aero Coronary IVL Catheter is based on years of user feedback. For example, it was built with improved deliverability and repositioning capabilities in mind.
Routine testing is needed to locate patients who may not benefit from clopidogrel
Up to 30% of U.S. patients carry genetic variations that reduce the effectiveness of clopidogrel, an antiplatelet medication sold under the brand name Plavix.
Key points to remember when performing cardiac ablations in ASCs
When CMS finalized coverage for cardiac ablations performed in ASCs, experts from HRS and ACC published recommendations for performing those procedures safely and effectively. One of the cardiologists behind that guidance shared some important takeaways with Cardiovascular Business.

Cardiac amyloidosis on nuclear imaging of the heart using 11C-PiB PET/CT. Image courtesy of RSNA

Cardiac amyloidosis in the spotlight at Heart Failure 2026

Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis .

AI healthcare doctor surgery procedure artificial intelligence

AI uses 12-lead ECGs to predict long-term stroke risk

Stroke is still a leading cause of death all over the world. A new AI model showed early potential to anticipate such adverse outcomes up to a decade in advance, ensuring high-risk patients receive the care they need.

Shockwave C2 Aero Coronary IVL Catheter from Shockwave Medical

J&J launches Shockwave Medical’s next-generation coronary IVL catheter

The Shockwave C2 Aero Coronary IVL Catheter is based on years of user feedback. For example, it was built with improved deliverability and repositioning capabilities in mind.

Routine testing is needed to locate patients who may not benefit from clopidogrel

Up to 30% of U.S. patients carry genetic variations that reduce the effectiveness of clopidogrel, an antiplatelet medication sold under the brand name Plavix.

Video: Samuel Jones, MD, MPH, FACC, director of Inpatient Electrophysiology at the Memorial Hospital for Chattanooga Heart Institute, and co-chair of the American College of Cardiology (ACC) and Heart Rhythm Society (HRS) guidance For electrophysiology ablation in ambulatory surgical centers (ASCs), explains the details of this shift in cardiology care delivery.

Key points to remember when performing cardiac ablations in ASCs

When CMS finalized coverage for cardiac ablations performed in ASCs, experts from HRS and ACC published recommendations for performing those procedures safely and effectively. One of the cardiologists behind that guidance shared some important takeaways with Cardiovascular Business.

Cardiologist finds possible link between sexual dreams and heart disease

More research is still necessary, but a new study has uncovered some noteworthy connections between dream frequency and the risk of heart disease.

Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipients

In cooperation with CareDx

Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.

Is TAVR too common among younger patients? New data prompt a ‘call to action’

Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.